Drug Database
Back to search

Finland· FI-REL-REL63584

Daybu

A trofinetide product containing trofinetide, registered in Finland by Acadia Pharmaceuticals (Netherlands) B.V.. The same ATC class is registered in 7 of our 19 countries.

ATC N07XX24

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedDaybuATCN07XX24REGISTER NO.FI-REL-REL63584PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about trofinetideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Trofinetide is registered in 7 of 19 countries.

Countries holding a registration under ATC N07XX24 (trofinetide), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose
Search trofinetide products by name

Trofinetide · ATC N07XX24

7 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Trofinetide
Manufacturer
Acadia Pharmaceuticals (Netherlands) B.V.
Country
Finland (FI)
ATC code
N07XX24
ATC class
Trofinetide
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Trofinetide in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trofinetide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9ce64133-4b80-4a0f-8911-8def2f64e786
GET /v1/drugs/9ce64133-4b80-4a0f-8911-8def2f64e786?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "oraaliliuos",
  "route": "Suun kautta",
  "ddd_unit": null,
  "strength": "200 mg/ml",
  "atc_label": "trofinetidi",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/26/2045/001",
  "fimea_rel_id": "REL63584",
  "authorised_at": "2026-08-20"
}
API referenceMCP serverPlans

See everything about trofinetide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console